Cargando…
Synergistic effects and mechanisms of impressic acid or acankoreanogein in combination with docetaxel on prostate cancer
Prostate cancer (PCa) is a common cancer among males and a leading cause of cancer deaths. Docetaxel (DOC) was recommended in guidelines as the first first-line drug of PCa; however, treatment with high doses of DOC ultimately results in resistance. This study examined the proliferation, viability,...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Royal Society of Chemistry
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9077455/ https://www.ncbi.nlm.nih.gov/pubmed/35541462 http://dx.doi.org/10.1039/c7ra11647k |